Skip to main content Skip to section navigation Skip to footer
  • Patient Resources
  • Posters & Publications
  • Media
  • Investors
  • Contact Us
Cellectar Biosciences, Inc. Corporate Page
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Partnerships
  • Our Science
    • Overview
    • Lipid Rafts in Cancer
    • PDC Platform & MOA
    • Tumor Types
  • Developmental Programs
    • Overview
    • Beta Emitter
    • Auger Emitter
    • Alpha Emitter
  • Clinical Trials
  • Patient Resources
  • Posters & Publications
  • Media
  • Investors
  • Contact Us

Clinical Trial Opportunity for Triple-Negative Breast Cancer

Learn More

IR Calendar

Investors

Investors

  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Presentations
    • Email Alerts
  • Company Info
    • Company Profile
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote & Chart
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Governance Overview
    • Board of Directors
    • Board Committees
    • Governance Documents

  • News & Events

  • Press Releases
  • IR Calendar
  • Presentations
  • Email Alerts

First Quarter 2026 Earnings Call

May 14, 2026 8:30 am EST
Earnings ReleaseHTML
Earnings WebcastAudio
10-QHTML XBRL Zip
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
  • account_treeSitemap
  • Connect With Us
  • About Us
  • Terms of Use
  • Privacy Policy
  • Disclaimer
  • Accessibility Policy
  • Sitemap

COMPANY INFORMATION

Cellectar Biosciences, Inc.
100 Campus Drive, Suite 207
Florham Park, NJ 07932

Tel: 608-441-8120
info@cellectar.com

SOCIAL MEDIA
Visit us on X Visit us on Instagram Visit us on Youtube Visit us on Facebook Visit us on Linkedin
© Copyright 2026 Cellectar Biosciences, Inc. All Rights Reserved.